ATG4B and breast neoplasm: These results indicate that BCc1, regardless of administration route, significantly reduces ATG-4B expression in breast tumor cells, with a magnitude of suppression comparable to cyclophosphamide—a chemotherapeutic known to activate autophagy as part of the cellular stress response.